Skip to main content
    C

    Cellebrite DI (CLBT)

    Official site

    TECHNOLOGY • SOFTWARE - INFRASTRUCTURE • NASDAQ

    $10.65
    -0.47 (-4.23%)

    Market Cap: $2.90B

    Last updated: Nov 17, 2026 at 4:31 PM ET

    Cellebrite DI (CLBT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cellebrite DI (CLBT) has a market cap of $2.90B. Its trailing P/E of 24.2x is below its 5-year median of 31.2x.

    Total Valuation

    Market Cap$2.90B
    Latest price (Nov 17, 2026)$10.65

    Key Dates

    The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 9, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.62% in the quarter ended Sep 30, 2026 and grew 10.40% a year over 2 years.

    Shares Outstanding254.36M
    Shares Change (YoY)+1.86%
    Shares Change (QoQ)+0.62%
    Share Count Growth (2Y CAGR)+10.40%

    Valuation Ratios

    Sales and book value multiples are 5.0x and 4.7x. Its year-end P/E ranged from 16.1x to 52.5x from 2021 to 2025.

    P/E Ratio24.2x
    Forward P/E18.4x
    P/S Ratio5.0x
    Forward P/S5.2x
    P/B Ratio4.7x
    P/TBV Ratio7.9x
    P/FCF Ratio16.8x
    P/OCF Ratio16.4x
    PEG Ratio1.5

    Valuation history and multiples

    Price Statistics

    The stock is down 42.28% over 52 weeks and trades 8.03% below its 50-day average.

    Beta (1Y)0.71
    52-Week Change-42.28%
    1-Month Change-4.44%
    3-Month Change-5.25%
    6-Month Change-20.88%
    5-Year Change+8.77%
    Total Return (1Y)-42.28%
    Total Return (3Y CAGR)+10.00%
    Total Return (5Y CAGR)+2.31%
    Return vs SPY (1Y)-53.36%
    Max Drawdown (1Y)-45.74%
    Max Drawdown (3Y)-59.85%
    Sharpe Ratio (1Y)-0.87
    Correlation with SPY (1Y)0.16
    50-Day Average$11.58
    200-Day Average$13.16
    52-Week Range$9.58 to $19.39
    RSI (14 Days)36.9
    Average Volume (20 Days)2.25M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.66x current liabilities.

    Current Ratio1.66x
    Quick Ratio1.65x

    Returns and Efficiency

    Return on equity is 11.26% and return on assets is 6.10% over the last 12 months.

    Return on Equity (ROE)11.26%
    Return on Assets (ROA)6.10%
    Return on Capital Employed (ROCE)13.92%
    ROA (5Y Average)0.62%
    ROIC (5Y Average)-40.34%
    Asset Turnover0.56x
    Inventory Turnover11.99x
    Receivables Turnover4.29x
    Cash Conversion Cycle42 days

    Taxes

    Income tax took 21.26% of pretax income over the last 12 months.

    Income Tax (TTM)$17.61M
    Effective Tax Rate21.26%

    Scores

    CLBT has an Altman Z-Score of 4.35, in the safe zone above 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score4.35
    Altman Z ZoneSafe
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $537.28M over the last 12 months is up 17.85% from the 12 months before.

    Revenue$537.28M
    Revenue Growth (YoY)+17.85%
    Gross Profit$441.99M
    Operating Income$64.42M
    Pretax Income$82.83M
    Net Income$65.23M
    EBITDA$122.86M
    EBIT$93.66M
    Reported EPS (TTM)$0.44

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 54.14% of the $1.07B in total assets.

    Cash and Equivalents$223.06M
    Working Capital$262.96M
    Shareholder Equity$579.31M
    Book Value Per Share$2.28
    Tangible Book Value$341.82M
    Tangible Book Per Share$1.34
    Total Assets$1.07B
    Total Liabilities$489.18M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $14.85M of capital spending, operating cash flow left $161.43M of free cash flow.

    Operating Cash Flow$176.28M
    Capital Expenditures$14.85M
    Free Cash Flow$161.43M
    FCF Per Share$0.64
    Depreciation and Amortization$29.20M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 11.99%, against a 5-year average of 8.88%.

    Gross Margin82.26%
    Operating Margin11.99%
    Pretax Margin15.42%
    Net Margin12.14%
    EBITDA Margin22.87%
    EBIT Margin17.43%
    FCF Margin30.05%
    Gross Margin (5Y Average)83.24%
    Operating Margin (5Y Average)8.88%
    Net Margin (5Y Average)-1.08%

    Growth

    Revenue grew 20.68% a year over 3 years, and EPS 22.80% a year.

    Revenue Growth (3Y CAGR)+20.68%
    Revenue Growth (5Y CAGR)+19.53%
    EPS Growth (3Y CAGR)+22.80%
    FCF Growth (3Y CAGR)+138.41%
    FCF Growth (5Y CAGR)+20.88%
    Operating Income Growth (3Y CAGR)+299.33%
    Book Value Per Share Growth (2Y CAGR)+230.83%

    Revenue and profit by year

    Dividends and Yields

    CLBT does not pay a dividend. Its free cash flow yield is 5.96%.

    Earnings Yield4.13%
    FCF Yield5.96%
    Shareholder Yield0.00%

    Peer Position

    Against 12 similar companies, CLBT has the 8th highest P/E.

    P/E Ratio24.2x vs 26.4x median
    P/S Ratio5.0x vs 1.8x median
    Revenue Growth (Trailing 4 Quarters, YoY)+17.85% vs +13.97% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 14.81% and EPS growth at 15.70% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+14.81%
    EPS Growth Forecast (2Y CAGR)+15.70%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CLBT

    What is CLBT's market cap?

    Cellebrite DI has a market cap of $2.90B.

    What is CLBT's P/E ratio?

    Cellebrite DI has a trailing P/E ratio of 24.2x and a forward P/E of 18.4x.

    How many shares of CLBT are outstanding?

    Cellebrite DI has 254.36M shares outstanding. The count is up 1.86% from a year earlier.

    Does CLBT pay a dividend?

    No. Cellebrite DI does not pay a dividend.